Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, Hepatitis B Virus Studies, and Hepatitis C virus research.
Incidence of Chronic Kidney Disease According to Steatotic Liver Disease and Its Subclassifications: A Longitudinal Cohort Study.
Systemic therapy for combined hepatocellular-cholangiocarcinoma: a comprehensive review of chemotherapy, immunotherapy, and targeted therapy
Changes in Sero-Immunological Status for Infectious Diseases in Solid Organ Transplantation: A 20-year Single-Center Study in Korea.
Optimal screening criteria for metabolic dysfunction-associated steatotic liver disease with fibrosis
Serum Ferritin Levels and Liver-Related Events in Individuals With Steatotic Liver Disease: A Longitudinal Cohort Study.
Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy-Induced HBsAg Seroclearance.
A Risk Prediction Model for Hepatocellular Carcinoma in the General Population Without Traditional Risk Factors for Liver Disease.
Head-to-Head Comparison of Long-Term HCC Risk of Antivirals-Treated Versus Untreated Low-Level Viremia in HBV-Compensated Cirrhosis.
Letter: Risk Prediction Model for HCC in Subjects Without Apparent Chronic Liver Disease: A Dilemma in Asia. Author's Reply.
Editorial: Hyperferritinaemia-An Ironclad Biomarker for the Prognostication of MASLD? Authors' Reply.
Letter: Iron Metabolism in SLD-A Complex Puzzle Yet to be Explored. Authors' Reply.
Clinical consequence of hypophosphatemia during antiviral therapy for chronic hepatitis B.
Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation
Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B.
Multidisciplinary approach for hepatocellular carcinoma patients: current evidence and future perspectives.
Analysis of Factors Predicting the Real-World Efficacy of Atezolizumab and Bevacizumab in Patients with Advanced Hepatocellular Carcinoma.
Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy.
Exploring the role of liver resection as a first-line treatment option for multinodular BCLC-A hepatocellular carcinoma.
Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on "Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study".
New nomenclature and subclassification of steatotic liver disease and loss of skeletal muscle mass: A longitudinal cohort study.
Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real-world multicenter cohort study.
Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation.
Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis.
Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII.
Associations of physical activity domains and muscle strength exercise with non-alcoholic fatty liver disease: a nation-wide cohort study.
Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study.
The association of non-alcoholic fatty liver disease between parents and adolescent children.
Pretransplant Functional Status Predicts Postoperative Morbidity and Mortality after Liver Transplantation in Patients with Cirrhosis.
Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
A model for predicting poor survival in patients with cirrhosis undergoing portosystemic shunt embolization.